General Hospital Psychiatry
Volume 25, Issue 2 , Pages 115-123 , March 2003

Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial

  • Thomas R. TenHave, PhD

      Affiliations

    • University of Pennsylvania Medical School, Philadelphia, PA, USA
    • Corresponding Author InformationCorresponding author. Tel.:+1-215-573-4885; fax:+1-215-573-4865.
    • ,
  • James Coyne, PhD

      Affiliations

    • University of Pennsylvania Medical School, Philadelphia, PA, USA
    • ,
  • Mark Salzer, PhD

      Affiliations

    • University of Pennsylvania Medical School, Philadelphia, PA, USA
    • ,
  • Ira Katz, MD, PhD

      Affiliations

    • University of Pennsylvania Medical School, Philadelphia, PA, USA
    • Veterans Administration Medical Center, Philadelphia, PA, USA

References 

  1. Ormel J, Kempen GI, Deeg DJ, et al.  Functioning, well-being, and health perception in late middle-aged, and older people (comparing the effects of depressive symptoms, and chronic medical conditions). J Am Geriatr Soc. 1998;46(1):39–48
  2. Callahan CM, Hendrie HC, Dittus RS, et al.  Improving treatment of late life depression in primary care (a randomized clinical trial). J Am Geriatr Soc. 1994;42:839–846
  3. Schulberg HC, Block MR, Madonia MJ, et al.  The “usual care” of major depression in primary care practice. Arch Fam Med. 1997;6:334–339
  4. Schulberg HC, Mulsant B, Schulz R, et al.  Characteristics and course of major depression in older primary care patients. Int J Psychiatry Med. 1998;28(4):421–436
  5. Thase ME. How should efficacy be evaluated in randomized clinical trials of treatments for depression?. J Clin Psychiatry. 1999;60(Suppl 4):23–31
  6. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations (a systematic review and meta-analysis). Am J Psychiatry. 1999;156(8):1182–1189
  7. Thase ME. Long-term nature of depression. J Clin Psychiatry. 1999;60(Suppl 14):3–9 [discussion 31–5]
  8. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression. Variable, substantial, and growing. JAMA. 2002;287:1840–1847
  9. Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psych. 2001;58:395–401
  10. AHCPR, Volume 2. AHCPR Guidelines (Depression Guideline Panel. Depression in Primary Care. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93–0551, 1993
  11. Alvidrez J, Azocar F. Distressed women’s clinic patients: preferences for mental health treatments and perceived obstacles. Gen Hosp Psychiatry. 1999;21(5):340–347
  12. Bakker A, Spinhaven P, van Balkom AJLM, Vleugel L, van Dyck R. Cognitive therapy by allocation versus cognitive therapy by preference in the treatment of panic disorder. Psychoth and Psychosom. 2000;69:240–243
  13. Bradley C. Psychological issues in clinical trial design. Irish J Psychol. 1997;18:67–87
  14. Morin C, Gaulier B, Barry T, Kowatch RA. Patients’ acceptance of psychological, and pharmacological therapies for insomnia. Sleep. 1992;15:302–305
  15. Walker J, Vincent N, Furer P, Cox B, Kjernisted K. Treatment preference in hypochondriasis. J Behav Ther Exp Psychiat. 1999;30:251–258
  16. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002;159:469–473
  17. Leon AC, Portera L, Olfson M, et al.  Diagnostic errors of primary care screens for depression and panic disorder. Int J Psychiat Med. 1999;29:1–11
  18. Wells KB, Sherbourne C, Schoenbaum M, et al.  Impact of disseminating quality improvement programs for depression in managed primary care (a randomized controlled trial). JAMA. 2000;283:212–220
  19. Coyne JC, Thompson R, Klinkman MS, Nease DE. Emotional Disorders in primary care. Emotional disorders in primary care. J Consult Clin Psychol 2002;70:798–809
  20. Corrigan PW, Salzer MS. The conflict between random assignment and treatment preference: implications for internal validity. Evaluation and Program Planning, (in press)
  21. Schulberg HC, Block MR, Madonia MJ, et al.  Applicability of clinical pharmacotherapy guidelines for major depression in primary care settings. Arch Fam Med. 1995;4(2):106–112
  22. Schulberg HC, Block MR, Madonia MJ, et al.  Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry. 1996;53(10):913–919
  23. Oxman TE, Barrett JE, Sengupta A, et al.  Status of minor depression or dysthymia in primary care following a randomized controlled treatment. Gen Hosp Psych. 2001;23(6):301–310
  24. Katon W, Vonkorff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Medical Care. 1992;30:67–76
  25. Stevens T, Katona C, Manela M, Watkin V, Livingston G. Drug treatment of older people with affective disorders in the community. Int’l J Ger Psychiatry. 1999;6:467–472
  26. Leff J, Vearnals S, Brewin CR, et al.  The London depression intervention trial (randomised controlled trial of antidepressants vs couple therapy in the treatment and maintenance of people with depression living with a partner: clinical outcome and costs). Br J Psychiatry. 2000;177:95–100
  27. Collins LM, Murphy SA, Bierman KA, Design, and evaluation of adaptive preventive interventions, (unpublished manuscript)
  28. Duan N, Wells KB, Braslow JT, Weisz JR. Randomized encouragement trial: a paradigm for public health intervention evaluation (unpublished manuscript)
  29. Katon W, Von Korff M, Lin E, et al.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiat. 1999;56:1109–1115
  30. Unutzer J, Katon W, Williams JW, et al.  Improving primary care for depression in late life (the design of a multicenter randomized trial). Med Care. 2001;39:785–799
  31. Wells KB. The design of Partners in Care (evaluating the cost-effectiveness of improving care for depression in primary care). Sociological Psychiatr Epidemiol. 1999;34:20–29
  32. Lavori PW, Dawson R. A design for testing clinical strategies (biased adaptive within-subject randomization). J Roy Stat Soc A Sta. 2000;163:29–38
  33. Zelen M. Play the winner rule and the controlled clinical trial. JASA. 1969;64:131–146
  34. Wei LJ, Smythe RT, Lin DY, Park TS. Statistical inference with data-dependent treatment allocation rules. JASA. 1990;85:156–162
  35. Editorial, British Journal of Obstetrics, and Gynaecology, 1997;104:1332–35
  36. Bedi N, Chilvers C, Churchill R, et al.  Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry. 2000;177:312–318
  37. Ward E, King M, Lloyd M, et al.  Randomised controlled trial of non-directive counseling, cognitive-behavior therapy, and usual general practitioner care for patients with depression. I. Clinical effectiveness. BMJ. 2000;321:1383–1388
  38. Bradley C. Patient preferences and clinical trial design and interpretation (appreciation and critique of a paper by Feine, Awad & Lund). Community Dentistry and Oral Epidemiology. 1999;27:85–88
  39. Feine JS, Awad MA, Lund JP. The impact of patient preference on the design and interpretation of clinical trials. Community Dentistry and Oral Epidemiology. 1998;26:70–74
  40. Cooper KG. The impact of using a partially randomized patient preference design when evaluating alternative managements for heavy menstrual bleeding. Brit J Obstet Gyn. 1997;104:1367–1373
  41. Brewin CR, Bradley C. Patient preferences and randomized clinical trials. BMJ. 1989;299:313–315
  42. Hunter MS, Liao KLM. Evaluation of a four-session cognitive-behavioral intervention for menopausal hot flashes. Br J Hlth Psych. 1996;1:113–125
  43. Chilvers C, Dewey M, Fielding K, et al.  Antidepressant drugs and generic counseling for treatment of major depression in primary care (randomised trial with patient preference arms). BMJ. 2001;322:1–5
  44. Lavori PW, Rush JA, Wisniewski SR, et al.  Strengthening clinical effectiveness trials (equipoise-stratified randomization). Arch Biol Psychiat. 2001;50:792–801
  45. Zelen M. A new design for randomized clinical trials. NEJM. 1979;300:1242–1246
  46. Zelen M. Randomized consent designs for clinical trials (an update). Statistics in Medicine. 1990;9:645–656
  47. Wells K. The design of partners in care (evaluating the cost-effectiveness of improving care for depression in primary care). Soc Psychiatry Epidemiol. 1999;34:20–29
  48. Rubin DB. More powerful randomization-based p-values in double-blind trials with non-compliance. Statistics in Medicine. 1998;17:371–385
  49. Murphy SA, Van der Laan MJ, Robins JM, CPPRG. Marginal mean models for dynamic regimes. J Am Stat Assoc 2001;96:1410–1423.
  50. Muthen B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999;55:463–469

☆ From time to time, the Journal receives manuscripts that can be thought of as opinion pieces, essays, or editorial comment on matters of topical interest. Such submissions will be refereed in the usual fashion and, if suitable, published in this section. The Editorial Board invites Letters to the Editor or rebutting commentary with the understanding that all submissions are subject to editing.

PII: S0163-8343(02)00275-X

doi: 10.1016/S0163-8343(02)00275-X

General Hospital Psychiatry
Volume 25, Issue 2 , Pages 115-123 , March 2003

Article Tools